Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 425-050-4 | CAS number: 10217-34-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
Introduction:
The acute oral and dermal toxicity of Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- is low, with LD50 being higher than 5000 mg/kg body weight for the oral and higher than 2000 mg/kg body weight for the dermal application. Therefore, an extensive toxicokinetic assessment is considered of limited value. An assessment of the anticipated toxicokinetic behaviour of Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- is given by an expert statement by K. Groen, Ph.D a staff member of NOTOX (TS 69579; NOTOX project 195097).
Absorption:
Because Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- is a liquid and the water solubility of the compound is relatively high (830 - 860 mg/l), intestinal exposure was not considered a rate-limiting factor for the absorption of the compound from the gastro-intestinal tract. Based on the stability data, its is anticipated that in the stomach (pH 1 -2) Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- is partially hydrolysed. A worst case absorption rate for dermal, oral and inhalation was taken as 100%.
Since it is generally accepted that substances with log Pow ranging from 0.1 to 6 penetrate the skin easily, it is anticipated that Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- with a log Pow = 4.1 - 5.0 (20°C) will penetrate the skin. This assumption is supported by the observations during the acute dermal toxicity study, where very slight edema and erythema was noticed.
Metabolism:
Both phase-I and phase-II metabolic enzymes may be involved in the metabolism of Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]-. Probably, deethylation of the silane group will be extensive. Furthermore, ring opening at the oxygen is anticipated. All of these metabolic steps are expected to lead to more water soluble and less toxic metabolites. The oxidative deethylation reaction requires enzymes that utilize the coenzyme NADPH, the cytochrome P-450 system and an NADPH regenerating system to provide the necessary oxygen and electrons to produce polar metabolites. Phase-II metabolism will probably be limited to sulphation and glucuronidation of the phase-I metabolites. The conjugates are expected to be easily eliminated via the kidneys.
Distribution:
Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- is anticipated to distribute to body water, with limited distribution into fatty tissues.
Conclusion:
Based on the expected kinetic behaviour in the body, as described above, the systemic exposure to Silane, triethoxy[2 -(7 -oxabicyclo[4.1.0]hept-3yl)ethyl]- will be limited and no accumulation in the body after prolonged exposure is anticipated. The anticipated kinetic behaviour is supported by the acute and subchronic toxicity data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)